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I. INTRODUCTION 
The objective of this report is to present to the Council and the European Parliament, in 
accordance with Article 26 of Directive 86/609/EEC of 24 November 1986 on the 
approximation of laws, regulations and administrative provisions of the Member States 
regarding the protection of animals used for experimental and other scientific purposes1, the 
statistical data on the number of animals used for experimental and other scientific purposes 
in the Member States of the EU. 
The first two statistical reports drafted in accordance with the provisions of the above 
mentioned directive which were published in 19942 and 19993, covering data on experimental 
animals collected in 1991 and 1996 respectively in the Member States, allowed only a limited 
                                                 
1 OJ L 358, 18.12.1986, p.1. 
2 COM (94) 195 final 
3 COM (1999) 191 final 
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amount of statistical analysis due to the absence of a consistent system of reporting the data. 
In 1997 an agreement was reached between the Commission and the competent authorities of 
the Member States to submit data for future reports using a format of eight harmonized tables. 
The third and fourth statistical reports published in 20034 and 20055 covering data collected in 
1999 and 2002 were based on these tables. This allowed a much wider interpretation of the 
results on the use of experimental animals in the EU. The Fifth Statistical Report, published in 
20076, contained for the first time data collected in the 10 Member States which joined the EU 
in 2004. In the Sixth Statistical Report the complete set of standardized tables provided by all 
27 Member States were successfully evaluated, although comparison of the results with 
previous reports was essentially qualitative owing to the addition of data from the new 
Member States. 
This Sixth Statistical Report includes data submitted by Romania and Bulgaria, which joined 
the EU in 2007. It gives an overview of the number of animals used in the Member States for 
experimental purposes for the year 2008, with the exception of one Member State which 
provided data from 2007, and summarizes the data and conclusions found in the Commission 
Staff Working Document – Sixth Report on the Statistics on the Number of Animals used for 
Experimental and other Scientific Purposes in the Member States of the European Union.  
II. DATA SUBMITTED AND GENERAL ASSESSMENT 
II.1. Data submitted by the Member States  
All 27 Member States submitted the data in the agreed EU format. The data quality control 
showed acceptable quality for the data submitted for 2008. This applies also to the new 
Member States Bulgaria and Romania who reported for the first time.  
The individual data from the Member States together with their respective comments and 
interpretations can be found in the Staff Working Document. 
II.2. General assessment 
As the two newest Member States Bulgaria and Romania have submitted data for the first 
time (representing below 1,0% of the total number of animals used in the EU 27), it is in 
principle not possible to draw accurate quantitative conclusions on the evolution of the use of 
animals for experimental purposes in the EU by comparing data with those of the previous 
reports. However, some comparisons in trends have been attempted, and significant changes 
in use have been highlighted in the report.  
The total number of animals used for experimental and other purposes in 2008 in the 27 
Member States EU (27) is just above 12,0 million.  
As in previous reports rodents together with rabbits represent more than 80% of the total 
number of animals used in the EU. Mice are by far the most commonly used species 
accounting for 59% of the total use, followed by rats with 17%.  
                                                 
4 COM (2003) 19 final 
5 COM (2005) 7 final 
6 COM (2007) 675 final 
 EN 5   EN 
The second most used group of animals was, as in previous years, cold-blooded animals 
which represent almost 10%. The third largest group of animals used was birds with a little 
over 6% of the total use. 
As stated in the previous two statistical reports no Great Apes were used in experiments in the 
EU in 2008.  
III. RESULTS  
III.1. Results of EU Table 1: Species and number of animals 
III.1.1. Results concerning species used 
Malta has hitherto reported no animal use for scientific purposes, but reported the use of 690 
animals in 2008.  
Mice (59%) and Rats (17%) were by far the most used species (Figure 1.1.).  
Figure 1.1
Percentages of animals used by classes in the Member
 States 
Mice 59,30%
Prosimians+monkeys+a
pes 0,08%
Other Mammals 
0,05%
Carnivores 
0,26%Artio+Perissodactyla 
1,39%
Birds 6,38%
Cold-blooded animals 
9,62%
Rabbits 2,78%
Guinea-Pigs 1,84%
Other rodents 0,60%
Rats 17,70%
 
Rodents together with rabbits represent more than 80% of the total number of animals used. 
The second most used group of animals was, as in the previous years cold-blooded animals 
namely reptiles, amphibians and fish representing 9,6% followed by birds with 6,3%. 
The Artiodactyla and Perissodactyla group including horses, donkeys and crossbreeds 
(Perrissodactyla), pigs, goats, sheep and cattle (Artiodactyla) represents 1,4% of the total 
number of animals used in the Member States. Carnivores represent 0,3% of the total number 
of animals used and non-human primates represent 0,08% of the animals used in 2008. 
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III.1.2. Comparison with the data of the previous reports  
The aim of this report is to indicate whether important changes have occurred related to use of 
different species, although rigorous comparisons cannot be made with previous reports. 
Comparison between proportions of classes of animals used in 1996, 1999, 2002, 2005 
and 2008 
Class of species 1996(*) 1999 2002(**) 2005(***) 2008(****) 
% Rodents-rabbits 81,3 86,9 78,0 77,5 82,2, 
% Cold-blooded animals 12,9 6,6 15,4 15, 9,6 
% Birds  4,7 5 5,4 6,4 
% Artio and Perissodactyla  1,2 1,2 1,1 1,4 
(*) 14 Member States reporting for 1996, one for 1997 
(**) 14 Member States reporting for 2002, one for 2001 
(***) 24 Member States reporting for 2005, one for 2004 
(****) 27 Member States reporting for 2008, one for 2007 
Overall, the percentage of rodents and rabbits shows some fluctuation, but remains close to 
80%. For cold-blooded animals the proportion used in 1996, in 2002 and 2005 is between 10 
to 15%. In 2008 the use of cold-blooded animals has dropped considerably to below 10%. 
However, in 1999 a much lower percentage of 6,6% was observed. Birds representing the 
third largest percentage of animals used, seems to be in constant increase over the years from 
4 to 6,4%. The group of horses, donkeys and cross-bred animals (perissodactyla) and pigs, 
goats, sheep and cattle (artiodactyla) fluctuates at around 1%. 
The inclusion of the data from Bulgaria and Romania did not lead to an increase in the total 
number of animals, on the contrary, there is a decrease of more than 116,500 animals. 
However, noticeable changes have occurred for the use of some individual species compared 
to data from the 2005 report.  
Significant increases occurred in 2008 for mice, rabbits, pigs and 'other birds' where 
percentage changes ranged from 5% to 28%. The increase in the number of mice used since 
2005 is 691,842 animals which represents 9,71% of the total number of mice used in 2008. 
The total number of pigs, goats, prosimians, and reptiles has increased by between 28 - 46%. 
On the other hand the total number of rats, guinea-pigs, other rodents, dogs, cattle and other 
mammals as well as amphibians and fish used has decreased substantially since the last report. 
When expressed in percentages these decreases range from more than 70% to around 10%.  
The largest percentile change has been noted in the decrease of the use of other carnivores. 
However, these species are not used in great numbers (from 8,711 to 2,853). There is also a 
large decrease of 75% in the total number of 'other mammals'.  
The following animals which are normally used in fewer numbers, show an increase in use: 
ferrets (16%), horses, donkeys and cross-breeds (11%), goats (44%) and reptiles (39%).  
It is also worth noting the large decrease in the use of new world monkeys of 73% as well as a 
decrease of 11% of old world monkeys. As in 2002 and 2005, no great apes were used for 
experimental or other scientific purposes in 2008. 
Member States provided examples of the type of species covered by category 'other' as 
follows: 
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Other rodents: gerbils, old world jerboas (Jaculus jaculus); chinchillas, beavers, ground 
squirrels, hamsters, grey dwarf hamsters (Cricetulus migratorius) and different species of 
mice. 
Other carnivores: wild-life species used for zoological and ecological studies e.g. foxes, 
badgers, seals, otters and fitchew. 
Other mammals: boars, bats and shrews, llamas, moles, European bison and red deer. 
Other birds: mainly Japanese Quail (coturnix japonica) and bob-white quail, poultry species, 
and zebra finches, canary, parakeet, parrot and farmed avian species for example, chickens. 
III.2. Results of EU Table 1: Origin of animals used 
According to the standardised EU tables the origin must only be reported for certain selected 
animal species. 
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The chart shows clearly that the majority of the species originated from EU countries. 
However, certain species such as cats, dogs, ferrets and old world monkeys are of non-
European origin. The origin of the species were quite similar to that observed in previous 
reports. However, for the first time in 2005 the prosimians used were all of EU origin and 
have remained so. A similar trend can also be observed with new world monkeys where 
almost all originate from either EU Member States or countries which are a party to the 
Council of Europe Convention ETS 123. Finally, also old world monkeys coming from the 
EU increased from about 26% in 2005 to more than 50% in 2008. The number of cats of EU 
origin also increased whereas dogs and ferrets of non-European origin have remained 
unchanged since 2005. 
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III.3. Results of EU Table 2: Purposes of the experiments 
More than 60% of animals were used in research and development for human medicine, 
veterinary medicine, dentistry and in fundamental biology studies (Fig 2). Production and 
quality control of products and devices in human medicine, veterinary medicine and dentistry 
required the use of 14,9% of the total number of animals. Toxicological and other safety 
evaluation represented 8,7% of the total number of animals used for experimental purposes.  
Figure 2
Purposes of experiments
Research and develop 
human +veterin+dentist 
22,8%
Fundamental biology 
studies 38,1%
Diagnosis of disease 
1,6%
Other 12,2%
Education and training 
1,7%
Production and quality 
control human medicine 
and dentistry  10,9%
Production and quality 
control veterinary 
medicine 4%
Toxicological and other 
safety evaluation 8,7%
 
Bearing in mind that the comparison aims to detect changes in trends rather than draw formal 
conclusions, the most significant change that has taken place since 2005 is that the number of 
animals used for research and development for human medicine, dentistry and veterinary 
medicine has dropped sharply from 31% to 22,8% (in terms of animal numbers the decrease is 
from 3,746,028 to 2,733,706). To be noted in particular was the significant reduction of more 
than 800,000 cold-blooded animals since the last report of 2005. On the other hand the 
percentage of animals used for fundamental biological research has increased from 33% to 
38% (that is, from 4,035,470 to 4,575,054) as well as for ‘other purposes’, from 8% to 12%. It 
should be underlined that both fundamental biology and research and development in human 
and veterinary medicine are the areas using by far the highest number of animals for 
experimental purposes in the EU. For additional details see the Staff Working Document.  
The number of animals used for toxicological and other safety evaluation has remained 
virtually unchanged since the last report and amounts to 8,7% of the total number of animals 
used for experimental purposes in the EU. This represents 1,042,153 animals. 
There is a substantial increase in the use of mice and rabbits for the production and quality 
control of products and devices for human medicine and dentistry', but also an increase in use 
of mice, pigs and birds for 'fundamental biological research' and in 'other experiments'. 
Several Member States confirmed that this increase in the use of mice is attributed to new 
research possibilities offered by the transgenic species. These animal models are being used 
for both human and animal health studies. An increase was also reported for the purpose of 
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experiments in anatomy and developmental biology, physiology, genetics and cancer 
research, and for immunology and microbiology. 
III.4. Results of EU Table 3: Toxicological and safety evaluation by type of 
product/endpoint 
The number of animals used for toxicological and other safety evaluation for different 
products or environmental test schemes amounts to 1,042,153, which represents 8,7% of the 
total number of animals used for experimental purposes in the EU. 
Of this total, animals used for toxicological or other safety evaluations of products or devices 
used for human medicine, veterinary medicine and dentistry represented 50,8% and was 
therefore the purpose using the largest number of the animals. The percentage of animals used 
for toxicological evaluation of three groups of products/substances, i.e. additives in food for 
human consumption, cosmetics and household products, is very small (1,18%) when 
compared to the other product groups. The percentages of animals used for toxicological or 
other safety evaluation of industrial and agricultural products are respectively representing 
7,1% and 7,9% of the number of animal used for that purpose (see Fig. 3). Other toxicological 
and safety evaluation represented more than 21%. 
Figure 3
Number of animals used in toxicological and other safety 
evaluation 
3.10    Other  toxicological 
or safety evaluations
21,45%
3.9   Potential  or actual 
contaminents in the 
general environment which 
do not appear in other 
columns
6,32
3.8    Products/ 
substances used or 
intended to be used mainly 
as additives in food for 
animal consumption
5,20%
3.7    Products/ 
substances used or 
intended to be used mainly 
as additives in food for 
human consumption
0,60%
3.6    Products/ 
substances used or 
intended to be used mainly 
as cosmetics or  toiletries
0,19%
3.5   Products/ 
substances used or 
intended to be used mainly 
in the household
0,41%
3.3     Products/ 
substances used or 
intended to be used mainly 
in agriculture
7,11%
3.4   Products/ 
substances used or 
intended to be used mainly 
in industry
7,91
3.2    Products/ 
substances or devices for 
human medicine and 
dentistry and for veterinary 
medicine
50,81%
 
There is a clear decrease in the number of animals used for toxicological tests for products 
intended for industry, for agriculture and for potential contaminants of the environment. The 
decrease ranges respectively from above 96,000 to about 82,000; from below 98,000 to about 
74,000 and from above 84,000 to about 65,000 in comparison to the data submitted in the 
2005 statistical report. There is also a significant decrease in the number of animals used for 
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testing of products for cosmetics and toiletries ranging from 5,500 to just below 2,000 (a 65% 
drop). This radical change should be seen in light of the legal requirement to phase out animal 
testing for cosmetics in the EU.  
There is, however, a significant increase since 2005 in the number of animals used for tests 
for additives in food for animal consumption (from 34,225 to 54,164). There is also a 
significant increase in the number of animals used for 'other' toxicological or safety evaluation 
(ranging from around 180,000 to about 220,000). Member States reported that this particular 
use of animals concerned new methods and tests, such as tests on transmission of 
microcystins on embryonic membrane, bioassays, toxicity evaluation for humans via the 
environment, and control of safety of toys. 
III.5. Results of EU Table 4: Animals used for studies of diseases  
The number of animals used in 2008 for studies of both animal and human diseases 
represented approximately 52% of the total number of animal used for experimental purposes.  
The proportion of animals used for studies of human diseases represents more than 90% of the 
total number of animals used for all disease studies. (Fig 4.1) 
Figure 4.1
Proportion of animals used for the studies of diseases
Human cancer 
(excluding evaluations 
of carcino hazards ) 
13,5%
Human nervous and 
mental disorders 
22,6%
Human cardiovascular 
diseases
6,4%
Other human diseases 
47,8%
Specific to animal 
diseases
9,7%
 
There has been a 50% decrease in animals used for studies on animal diseases - from 
1,329,000 to 614,000. The use of cold-blooded species has decreased from around 954,000 
animals in 2005 to 43,914 in 2008. However, the use of mice has increased substantially. 
Around 35% of the increase (about 681,000) can be attributed to disease studies. 
There has also been an increase in the number of birds used for studies on animal diseases. 
Member States reported studies on bird flu, Gumboro disease and bronchitis including studies 
on quality and safety of vaccines. 
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Figure 4.2
Proportion of animals used by classes per type of studies of diseases
Specific to animal diseases %
Other human diseases %
Human cancer (excluding evaluations of
carcino hazards ) %
Human nervous and mental disorders %
Human cardiovascular diseases %
 
In Figure 4.2 the top of each bar shows the relative percentage of animals used for studies on 
specific animal diseases. Significant numbers of both artiodactyla and perissodactyla and 
birds are used for this purpose. Member States reported that it is still current practice to test 
vaccines on these species. However, in some Member States birds are only used if the 
infection concerns bird species. 
III.6. Results of EU Table 5: Animals used in production and quality control of products 
for human medicine and dentistry and for veterinary medicine 
The number of animals used in tests for the production and quality control of products for 
human medicine and dentistry and for veterinary medicine represents 14,9% of the total 
number of animals used for experimental purposes. 
The largest proportion of animals in this area (47%) was used to satisfy requirements from 
several pieces of legislation (national, from the EU, the Council of Europe member country 
legislation, and from legislation outside of the EU (Fig 5)). 41,1% of the animals were used to 
satisfy EU legislative requirements including the European Pharmacopoeia.  
 EN 12   EN 
Figure 5
Percentages of animals used for regulatory requirements for the  production and 
quality control of products and devices for human medicine, dentistry and for 
veterinary medicine
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5.6      Any combination of 5.2/
5.3/ 5.4/ 5.5
 5.7       No regulatory
requirements
 
In comparison to the last report there is a net increase in the number of animals used to satisfy 
simultaneously several pieces of legislation. On the other hand there is a net increase of tests 
carried out to satisfy EU legislation including the European Pharmacopoeia. Consequently, 
there is a net decrease in the number of animals used to satisfy national legislation, which is 
an encouraging trend showing an attempt to move towards EU harmonisation of regulatory 
requirements. 
III.7. Results of EU harmonized Table 6: Origin of regulatory requirements for animals 
used in toxicological and other safety evaluations 
As pointed out earlier, the number of animals used in toxicological or other safety evaluation 
represents 8,7% of the total number of animals used for experimental purposes in the EU. 
Of this total, animals used to simultaneously satisfy regulatory requirements from several 
pieces of legislation covered almost half of the animals used in this area (50%). The testing 
required under EU legislation including the European Pharmacopoeia accounted for the 
second highest percentage in this area, namely 24%. 
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Figure 6
Percentages of animals used for regulatory requirements for toxicological and other 
safety evaluation  
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6.6      Any combination of 6.2/
6.3/ 6.4/ 6.5
 6.7       No regulatory
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In comparison to the last report there is a slight decrease in the proportion of animals used to 
simultaneously satisfy several pieces of regional legislation from 54% to 50%.  
On the other hand there is a substantial increase in the proportion of animals used for no 
regulatory requirements from 5 to over 15,0%. In order to explain what is meant by the term 
'no regulatory requirements', some Member States gave as an example projects using in-house 
methods to verify the safety and efficacy of veterinary biologicals and medicinal products 
using animals, and carried out according to a company’s standards. The results may be 
accepted by that Member State national authority, although not required by legislation. 
The testing carried out in 2008 to satisfy national legislation specific to a single Member State 
showed a decrease of about 7,500 animals which represents roughly a 1,2% decrease 
compared to the last report. 
III.8. Results of EU Table 7: Animals used in toxicity tests for toxicological and other 
safety evaluations 
The largest percentage (almost 45%) of use of animals in toxicological and other safety 
evaluations is due to acute and sub-acute toxicity tests. Also taking into account sub-chronic 
and chronic toxicity, the percentage of animals used in short and long term systemic toxicity 
testing accounts for 55% in this area (Fig 7). 
13,7% of animals were used for testing carcinogenicity, mutagenicity and toxicity to 
reproduction. Another important category of use of animals in 2008 was for 'other tests' with 
24%. Breaking down further the category 'other', Member States reported testing in areas such 
as biological screening for pharmaceutical, healthcare and veterinary products. This includes 
neurotoxicity, toxicokinetics, testing of biological evaluation of medical devices: 
Intracutaneous testing of reactivity in rabbits, studies into the penetration of nanoparticles 
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through tissue and their biocompatibility, studies into the evaluation of sensitization potential 
of dyestuffs used in the textile industry and pharmacological studies included in safety tests. 
Figure 7
Percentages of animals used in toxicity tests for toxicological
 and other safety evaluation
44,99
4,61
9,88
4,58
9,13
2,41
24,40
0,00 10,00 20,00 30,00 40,00 50,00
Acute and sub-acute toxicity testing
methods (including limit test)
Irritation /sensitization tests
 Sub- chronic and chronic toxicity
Mutagenicity and carcinogenicity
Reproductive and developmental
toxicity
Toxicity to aquatic vertebrates not
included in other columns
other
 
There is a continuous increase over the last three reports of the proportion of animals used for 
acute and sub-acute tests, ranging from 36% - 42% to almost 45% respectively. Since the last 
report, this represents in animal numbers an increase of more than 37,000 animals. Member 
States attributed the increase in part to several phases in new product development and new 
legislation, for example requiring that all generic substances should be tested. 
On the other hand there is a steady decrease over the last three reports of the animals used for 
reproductive toxicity testing from: 12% to 10% and to 9% respectively. In terms of animals it 
means a saving since the 2005 report of 8,650 animals. 
III.9. Results of EU Table 8: Type of toxicity tests carried out for toxicological and other 
safety evaluations of products 
Figure 8 shows that the majority of animals tested in acute/sub-acute toxicity are intended for 
the purpose of human medicine, dentistry and veterinary medicine. This is followed by tests 
carried out for other toxicological or safety evaluations, and then for agriculture and industrial 
products.  
The treatment and interpretation of the data on animals used for toxicity tests with regard to 
the type of products was done for the first time in the Fifth Statistical Report. However, 
because the graph in that report represented more the relative importance of tests within a type 
of product rather than the proportion of animals used per type of test for the different 
products, the graph was modified accordingly for this report. 
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Figure 8
Proportion of animals used for toxicity tests for toxicological and other safety evaluation by 
types of products 
 A) for human medicine, dentistry and for
veterinary medicine   
B) used  in agriculture
C) used in industry
D) used  in the household
E) used as cosmetics or  toiletries
F) additives in food for human
consumption
G) additives in food for animal
consumption
H) potential  or actual contaminents in
the general environment 
I)  other  toxicological or safety
evaluations
 
Products intended for medicine, dentistry and veterinary medicine require the highest 
proportion of animals for the different types of tests i.e. approximately 50%. The next highest 
proportion is for ‘other’ toxicological evaluations, above 20%, followed by animals used in 
tests for products for agriculture and for industry each above 7%. 
